Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urachus | 1 | 2023 | 1 | 0.850 |
Why?
|
| Urethra | 1 | 2023 | 2 | 0.850 |
Why?
|
| Emphysema | 1 | 2016 | 2 | 0.550 |
Why?
|
| Pyelonephritis | 1 | 2016 | 2 | 0.550 |
Why?
|
| Nocturnal Enuresis | 1 | 2024 | 3 | 0.240 |
Why?
|
| Urinary Bladder Diseases | 1 | 2023 | 1 | 0.210 |
Why?
|
| Umbilicus | 1 | 2023 | 1 | 0.210 |
Why?
|
| Peritoneal Diseases | 1 | 2023 | 2 | 0.210 |
Why?
|
| Urinary Tract | 1 | 2023 | 4 | 0.210 |
Why?
|
| Child, Preschool | 6 | 2021 | 1748 | 0.200 |
Why?
|
| Infant | 7 | 2021 | 2244 | 0.190 |
Why?
|
| Humans | 9 | 2024 | 14537 | 0.170 |
Why?
|
| Specimen Handling | 1 | 2019 | 105 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 34 | 0.140 |
Why?
|
| Radiography, Abdominal | 1 | 2016 | 2 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2016 | 21 | 0.140 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2017 | 103 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 61 | 0.130 |
Why?
|
| Kidney | 1 | 2016 | 46 | 0.130 |
Why?
|
| Child | 4 | 2024 | 2242 | 0.120 |
Why?
|
| Streptococcus pneumoniae | 1 | 2017 | 336 | 0.120 |
Why?
|
| Pneumococcal Vaccines | 1 | 2017 | 278 | 0.110 |
Why?
|
| Pneumococcal Infections | 1 | 2017 | 299 | 0.110 |
Why?
|
| Female | 6 | 2021 | 9103 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2021 | 1479 | 0.070 |
Why?
|
| South Africa | 5 | 2024 | 7596 | 0.070 |
Why?
|
| Male | 5 | 2021 | 6754 | 0.070 |
Why?
|
| Haemophilus Infections | 2 | 2002 | 23 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2019 | 1160 | 0.060 |
Why?
|
| HIV-1 | 3 | 2002 | 1260 | 0.060 |
Why?
|
| Adolescent | 2 | 2021 | 2985 | 0.050 |
Why?
|
| Parainfluenza Virus 1, Human | 1 | 2002 | 2 | 0.050 |
Why?
|
| Parainfluenza Virus 2, Human | 1 | 2002 | 2 | 0.050 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2002 | 5 | 0.050 |
Why?
|
| Paramyxoviridae Infections | 1 | 2002 | 27 | 0.050 |
Why?
|
| Haemophilus influenzae type b | 1 | 2002 | 17 | 0.050 |
Why?
|
| Haemophilus Vaccines | 1 | 2002 | 41 | 0.050 |
Why?
|
| Seizures | 1 | 2021 | 20 | 0.050 |
Why?
|
| Respiratory Tract Diseases | 1 | 2021 | 21 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2021 | 22 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 47 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2000 | 54 | 0.040 |
Why?
|
| Diagnosis | 1 | 2019 | 7 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2019 | 13 | 0.040 |
Why?
|
| Community-Acquired Infections | 1 | 2000 | 102 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 140 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2002 | 266 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 179 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2000 | 195 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 221 | 0.040 |
Why?
|
| HIV Infections | 3 | 2017 | 5097 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2017 | 21 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2017 | 29 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 42 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2017 | 38 | 0.030 |
Why?
|
| Immunization, Secondary | 1 | 2017 | 72 | 0.030 |
Why?
|
| Serogroup | 1 | 2017 | 150 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2017 | 153 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 231 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2002 | 61 | 0.010 |
Why?
|
| Seasons | 1 | 2002 | 154 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 2002 | 104 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 26 | 0.010 |
Why?
|
| Haemophilus influenzae | 1 | 2000 | 42 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2000 | 31 | 0.010 |
Why?
|
| Bacteremia | 1 | 2000 | 79 | 0.010 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2000 | 100 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 967 | 0.010 |
Why?
|
| Prevalence | 1 | 2002 | 1192 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2000 | 324 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2000 | 329 | 0.010 |
Why?
|